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a b s t r a c t
In the decade since Disrupted in Schizophrenia 1 (DISC1) was ﬁrst identiﬁed it has become one of the most
convincing risk genes for major mental illness. As a multi-functional scaffold protein, DISC1 has multiple
identiﬁed protein interaction partners that highlight pathologically relevant molecular pathways with
potential for pharmaceutical intervention. Amongst these are proteins involved in neuronal migration
(e.g. APP, Dixdc1, LIS1, NDE1, NDEL1), neural progenitor proliferation (GSK3b), neurosignalling (Girdin,
GSK3b, PDE4) and synaptic function (Kal7, TNIK). Furthermore, emerging evidence of genetic association
(NDEL1, PCM1, PDE4B) and copy number variation (NDE1) implicate several DISC1-binding partners as
risk factors for schizophrenia in their own right. Thus, a picture begins to emerge of DISC1 as a key hub
for multiple critical developmental pathways within the brain, disruption of which can lead to a variety
of psychiatric illness phenotypes.
This article is part of a Special Issue entitled ‘Schizophrenia’.
 2011 Elsevier Ltd. All rights reserved.
1. Introduction
A key objective of genetics and genomics research into psychi-
atric illness is to identify perturbed biological pathways and, as
a consequence, potential targets for pharmacological intervention.
The genetic entrée point need not itself explain a large fraction of
the liability to schizophreniae it is sufﬁcient that genetic abrogation
can cause schizophrenia. DISC1 and the extended DISC1 pathway
illustrate this contention par excellence. DISC1 was identiﬁed
through a unique family in which a chromosomal translocation
event co-segregates strongly with major mental illness (Blackwood
et al., 2001; St Clair et al., 1990). This translocation event directly
disrupts both a protein coding gene, DISC1, and an antisense RNA
only gene, DISC2 (Millar et al., 2000). In the intervening period, the
DISC locus has been repeatedly implicated in psychiatric illness by
genetic linkage, association and mutation detection (reviewed in
Chubb et al., 2008, see Table 1 for references and summaries of
recent studies). Some studies have also pointed to epistatic inter-
actions between the DISC locus and other candidate genes (Burdick
et al., 2008; Hennah et al., 2007; Nicodemus et al., 2010). Despite
these many conﬁrmatory studies, there are also negative studies
(Chubb et al., 2008 and references in Table 1) and, as yet, no ﬁrm
basis on which to estimate the proportion of genetic liability
attributable to the DISC locus. The DISC locus has appeared as
a gene-wide, but not a genome-wide ﬁnding in some (Sullivan et al.,
2008) but not other (Sanders et al., 2008) studies. The critical issue is
what we can learn from the identiﬁcation of DISC1 regarding the
speciﬁcs and generalities of the biological underpinning of schizo-
phrenia and other major mental illness.
The DISC1 protein has no known enzymatic activity; rather it
exerts its effect onmultiple proteins through interaction tomodulate
their functional states and biological activities in time and space.
Many putative interacting proteins have been identiﬁed through
extensive yeast-2-hybrid screening (Brandon et al., 2004; Camargo
et al., 2007; Millar et al., 2003; Morris et al., 2003; Ozeki et al.,
2003) and, where these have been examined, a large proportion
have been validated by downstream experimentation (reviewed in
Chubb et al., 2008). These multiple interactions, combined with the
widespread subcellular distribution of DISC1 (reviewed in Chubb
et al., 2008), a complex pattern of protein isoforms (James et al.,
Abbreviations: APP, Amyloid precursor protein; ATF4, Activating transcription
factor 4; BACE1, b-site APP-cleaving enzyme-1; BBS4, BardeteBiedl syndrome 4;
CEP290, Centrosomal protein 290 kDa; CNV, Copy number variation; CRE, cAMP
response element; DBZ, DISC1-binding zinc ﬁnger; DISC1, Disrupted in schizo-
phrenia 1; Dixdc1, Dishevelled-axin domain containing-1; FEZ1, Fasciculation and
elongation protein zeta 1; GluR, Glutamate receptor; GSK3b, Glycogen synthase
kinase 3b; Kal7, Kalirin-7; LEF/TCF, Lymphoid enhancer factor/T cell factor; LIS1,
Lissencephaly 1; mTOR, Mammalian target of rapamycin; NDE1, Nuclear distribu-
tion factor E homologue 1 or Nuclear distribution element 1; NDEL1, NDE-like 1;
NRG, Neuregulin; PACAP, Pituitary adenylate cyclase-activating polypeptide; PCM1,
Pericentriolar material 1; PCNT, Pericentrin; PDE4, Phosphodiesterase 4; PI3 K,
Phosphatidylinositiol 3-kinase; PSD, Post-synaptic density; Rac1, Ras-related C3
botulinum toxin substrate 1; TNIK, Traf2 and Nck interacting kinase.
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Table 1
Studies investigating genetic links between the DISC locus or the adjacent TSNAX locus and major mental illness, an endophenotype thereof or, in one study, chronic fatigue
syndrome published since those reviewed by Chubb et al. (2008). SNPs bracketed together indicate haplotypes. SNPs separated by a hyphen () indicate signiﬁcance when
alleles are considered together, but not independently.
Study Sample Condition/phenotype SNP, haplotype, marker or variant Notes
Positive genetic association studies
Palo et al. (2007) Finnish families Psychotic disorders (rs1655285, rs751229) Males only
(rs751229, rs3738401) Males only
(rs751229, rs3738401, rs1538977) Males only, principally those without
bipolar spectrum disorder
(rs1655285, rs751229, rs3738401) Males only, principally those with
bipolar spectrum disorder
Bipolar spectrum disorders rs1655285
(rs1630250, rs1615409) Principally those without
psychotic disorder








rs1615409 Signiﬁcant by two measures
rs821616 Signiﬁcant by one measure
rs980989 Signiﬁcant by three measures
Attention/working memory rs980989 Signiﬁcant by three measures
Verbal learning rs751229 Signiﬁcant by two measures
rs1322784 Signiﬁcant by one measure
rs1000731 Signiﬁcant by one measure
rs980989 Signiﬁcant by two measures
Executive functions rs821616 Signiﬁcant by one measure
Kilpinen et al. (2008) Finnish families Autism D1S2709
Asperger’s syndrome rs1322784 Males only
(rs751229, rs3738401)
(rs751229, rs3738401, rs1322784) Males only
Kim et al. (2008a) Korean Schizophrenia with
poor concentration
rs821616
Perlis et al. (2008) American trios Bipolar disorder (rs10495308, rs2793091, rs2793085)
Saetre et al. (2008) Danish Schizophrenia rs3737597
Norwegian Schizophrenia rs3737597
Swedish Schizophrenia rs3737597
Hennah et al. (2009) Finnish Bipolar disorder rs1538979 Males only
English Bipolar disorder rs821577 Females only
British/Finnish Schizophrenia rs821633-rs1538979 Females only.
Rastogi et al. (2009) Canadian families Schizophrenia (rs11122359, rs701158)
(rs6675281, rs11122359)
(rs701158, rs821597)





Schizophrenia 18x haplotyes 5 in males only, 11 in females only
rs1538979 Signiﬁcant in males when
stratiﬁed on rs821633 allele
Tomppo et al. (2009b) Finnish Social anhedonia rs821577
rs11122381 Females only.
rs821592 Females only.
rs821633 Signiﬁcant when stratiﬁed on
rs1538979 and rs821577 alleles
Fukuda et al. (2010) Japanese Chronic fatigue syndrome rs821616 Females only.
Harris et al. (2010) Scottish, elderly Anxiety scores rs821577 Lower in males, higher in females
rs821633 Lower in males, higher in females
Depression scores rs821577 Females only
rs821633 Females only
Emotional stability scores rs821577 Females only
rs821633 Females only




French trios Schizophrenia rs6675281
Negative symptom scores rs6675281
Algerian trios Schizophrenia rs821616
Negative symptom scores rs6675281
Mouaffak et al. (2010) French Ultra-resistant schizophrenia rs3738401
Nicodemus et al. (2010) American Schizophrenia rs10744743-rs1411771 rs10744743 is an SNP
in the CIT gene
Okuda et al. (2010) Japanese Major depressive disorder rs766288 Females only





British Major depressive disorder (rs7546310, rs821597)
(continued on next page)
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2004) and splice variants (Nakata et al., 2009), have led to the
suggestion that DISC1 acts as a protein scaffold within the cell,
dynamically interacting with and affecting the function of different
proteins at different locations and developmental times (Brandon
et al., 2009; Porteous, 2008; Porteous and Millar, 2009). DISC1-
related psychiatric illness is therefore likely to arise through the
simultaneous dysregulation of not just one, but more likely several,
protein interactions, physiological states and activities, with a conse-
quential complexity and pervasiveness of effect. Identifying the key
DISC1 interactors is therefore of exceptional importance in coming to
understand the nature of the devastating condition that is schizo-
phrenia, and will facilitate the search for downstream elements
which may be susceptible to pharmaceutical intervention.
In this review, we will focus on what is known about the bio-
logical functions of DISC1-interacting proteins, with particular
attention to aspects of their biology which potentially relate to
psychiatric illness, through effects on neurodevelopment, neuro-
transmission or neurosignalling, along with the emerging genetic
evidence implicating many of these as schizophrenia-risk factors in
their own right. Whereas a neurodevelopmental component to
schizophrenia is well established, and pre-morbid features are rec-
ognised, it is typically not until adolescence or early adulthood that
the debilitating symptoms emerge. That DISC1 and its pathway of
interacting proteins affect both neurodevelopmental pathways and
also signalling pathways in the adult brain, suggest that the study of
DISC1 genetics and biology may help towards a more uniﬁed
understanding of schizophrenia andwith it the potential to develop
rational interventions in the symptomatic adult and or even earlier.
2. Roles of DISC1-interacting proteins in neural development
2.1. DISC1-binding partners in cytoskeletal functions and neurite
outgrowth
The complex and intricate task of co-ordinating the microtubule
network of neurons, which is vital for maintaining correct devel-
opment, morphology and migration, is performed in large part by
the microtubule organising centre, or centrosome (Higginbotham
and Gleeson, 2007). Multiple lines of evidence demonstrate that
DISC1 is part of a protein complex at the centrosome (Fig. 1 and
references in the legend) and is involved in cytoskeletal processes
involved in neuronal migration, including nucleokinesis and neu-
rite outgrowth. LIS1, NDE1, and NDEL1 are a trio of such cen-
trosomal DISC1 interactors (Bradshaw et al., 2009; Brandon et al.,
2004; Burdick et al., 2008; Millar et al., 2003; Morris et al., 2003;
Ozeki et al., 2003) which play pivotal roles in the progression of
the cell cycle, dynein-related transport along microtubules and
nucleokinesis (reviewed in Chubb et al., 2008; Wynshaw-Boris
et al., 2010). The localisation of NDEL1 and LIS1 in axons is
known to be dependent on expression of DISC1 (Taya et al., 2007).
Knock-down of either NDEL1 or LIS1 using RNAi in culture leads to
reduced neurite outgrowth (Kamiya et al., 2006; Shim et al., 2008;
Taya et al., 2007), while granule neurons from heterozygous NDEL1
or LIS1 knock-out mice show impaired migration in in vitro assays
(Toyo-oka et al., 2005). NDEL1 is also known to play a role in axon
regeneration after injury (Toth et al., 2008) and has an additional
DISC1-modulated function as a cysteine endopeptidase (Hayashi
et al., 2005) which appears to be important for regulation of neu-
rite outgrowth (Hayashi et al., 2010). Although highly similar in
amino-acid sequence to NDEL1, the role of NDE1 in many of these
processes has yet to be determined.
DISC1 is also known to be involved in transport along micro-
tubules to the distal parts of axons as part of a ternary complex with
kinesin-1 and the adaptor protein Grb2 (Shinoda et al., 2007; Taya
et al., 2007). Cargo transported in this manner includes the DISC1
interactors LIS1, NDEL1 and 14-3-33 (Taya et al., 2007). The inter-
action of DISC1 with Grb2 may also be required for neutrophin-
3-related axon elongation (Shinoda et al., 2007). Of potential
therapeutic relevance, expression of GRB2 mRNA is known to be
upregulated following electroconvulsive seizure, an established
anti-depression therapy (Newton et al., 2004). FEZ1, another DISC1-
interacting protein (Miyoshi et al., 2003), is known to be involved in
the activation of the kinesin-1 motor protein (Blasius et al., 2007;
Fujita et al., 2007), regulation of neurite outgrowth (Fujita et al.,
2007) and the establishment of neuronal polarity (Ikuta et al.,
2007). DISC1-FEZ1 interaction is enhanced during neuro-
differentiation, and expression of the FEZ1-binding domain of
DISC1 has a dominant negative effect on neurite outgrowth in
a cellular model (Miyoshi et al., 2003), implying co-operation of
DISC1 and FEZ1 in this signalling pathway.
At the centrosome, DISC1 also interacts with the scaffold protein
pericentrin (also known as kendrin,Miyoshi et al., 2004), amolecule
Table 1 (continued )
Study Sample Condition/phenotype SNP, haplotype, marker or variant Notes









Sanders et al. (2008) European ancesrtry Schizophrenia Negative
Lim et al. (2009) Korean Autism spectrum
disorders
Houlihan et al. (2009) Scottish, elderly Cognitive traits Negative
Okuda et al. (2010) Japanese Bipolar disorder Negative
Ultra-rare variants
Song et al. (2008) Single patients Schizophrenia Point mutations: G14A, R37 W,
S90L, R418H, T603I
Not in 10,000 þ sequenced controls.
S90L seen in two patients
Crepel et al. (2010) Two brothers Autism 2 Mb duplication including
DISC locus
Not in 1577 controls
Williams et al. (2009) Single patient Autism spectrum
disorder
2 Mb deletion including
TSNAX/DISC locus
Song et al. (2010) Single patients Bipolar disorder Point mutations: S209R R338Q,
R418H, T754S
Not in 10,000 þ sequenced controls
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that is known to play important roles inmicrotubule nucleation and
aster formation (reviewed in Delaval and Doxsey, 2010) in a seem-
ingly DISC1-dependent manner (Shimizu et al., 2008). Intriguingly,
mutations in the PCNT gene, which encodes pericentrin, are heavily
implicated in a form of dwarﬁsm associatedwith reduced brain size,
suggesting it to be important for neurodevelopment (Grifﬁth et al.,
2008; Rauch et al., 2008). Recruitment of pericentrin to the
centrosome is essential for correct microtubule organisation and is
facilitated by another large scaffold protein PCM1 (Dammermann
and Merdes, 2002). PCM1 in turn is recruited co-operatively by
interacting proteins DISC1 and BBS4 (Kamiya et al., 2008). Cen-
trosomal PCM1 is known to be required for correct axon
morphology (Calderon de Anda et al., 2010) and embryonic neuro-
genesis (Ge et al., 2010). Intriguingly, the level of localisation of
PCM1 to the centrosome in human glial cells is altered by two
commonDISC1 amino-acid substitutions, Ser704Cysand Leu607Phe
(Eastwood et al., 2010), one possible mechanism by which these
alleles lead to DISC1 dysfunction, as measured by brain imaging
(Callicott et al., 2005; Di Giorgio et al., 2008; Hashimoto et al., 2006;
Prata et al., 2008; Szeszko et al., 2008; Takahashi et al., 2009) and
elevated risk of psychiatric illness (Table 1 and references therein).
Other centrosomal interactors of DISC1 include the DISC1-
Binding Zinc ﬁnger protein (DBZ, also known as Su48 or ZNF365).
DBZ is a brain expressed protein which binds to DISC1, NDE1 and
NDEL1 (Camargo et al., 2007; Hattori et al., 2007; Hirohashi et al.,
2006; Wang et al., 2006). Co-expression of DISC1 and DBZ results
in a reduction in the number of PC12 cells bearing neurites, while
expression of the DISC1-binding domain of DBZ lead to reduced
neurite outgrowth in mouse primary hippocampal neurons
(Hattori et al., 2007).
2.2. DISC1-binding proteins in neuronal migration and
differentiation within the mouse brain
Results from cell-based models such as those described above
beg the question as to how binding partners of DISC1 might be
involved in regulating neurodevelopment. Important insights have
come from various in vivo mouse studies. In the hippocampus,
knock-down of DISC1 using shRNA methods have been shown to
lead to aberrant positioning and dendritic structure of adult-born
neurons (Duan et al., 2007). Intriguingly, the defects caused by one
DISC1 shRNA of mild effect were greatly enhanced by co-expression
of an shRNA to knock-down levels of NDEL1 (Duan et al., 2007),
strongly implying that these two proteins co-operate together, and
consistent with the role of NDEL1 established in cultured cells.
Deﬁciencies in the migration of neurons in the developing cortex
can be seen following silencing of DISC1, PCM1 or BBS4 (Calderon de
Anda et al., 2010; Kamiya et al., 2005, 2008) and in NDE1 andNDEL1
knock-out mice (Feng and Walsh, 2004; Sasaki et al., 2005)
implying that the various DISC1-containing complexes involved in
microtubule regulation are critical for cortical development.
Migration defects in cortical neurons can also be caused by
silencing the DISC1-interacting protein Dixdc1 or by inhibiting
DISC1-Dixdc1 interaction using an interfering peptide (Singh et al.,
2010). Intriguingly, Dixdc1 is also an interactor of NDEL1, and
a phosphorylation site key to this interaction is required to rescue
migration defects caused by suppression of DIXDC1 expression
(Singh et al., 2010). Thus, DISC1, Dixdc1 and NDEL1 appear to co-
operate in regulating migration in the developing cortex. Another
potential member of this pathway is the Alzheimer’s disease-
related Amyloid Precursor Protein (APP, Young-Pearse et al., 2010).
Knock-down of APP levels by RNAi in the developing cortex leads to
migration defects reminiscent of DISC1 knock-down which can be
largely reversed by DISC1 over-expression (Young-Pearse et al.,
2007, 2010). There is also evidence to suggest that APP is
involved in the localisation of DISC1 to the centrosome in the cortex
(Young-Pearse et al., 2010).
Both Dixdc1 and DISC1 impact on the Wnt-signalling pathway.
Silencing of DISC1 or Dixdc1 reduces lymphoid enhancer factor/T
cell factor (LEF/TCF)mediated transcription and thus differentiation
of neural progenitors (Mao et al., 2009; Singh et al., 2010). These
effects caused by down-regulation of DISC1 expression can be
rescued by expression of Dixdc1 and vice versa. The key linking
molecules are Glycogen Synthase Kinase 3b (GSK3b) and b-catenin.
The kinase activity of GSK3b is inhibited on binding to DISC1 (Mao
et al., 2009), preventing degradation of b-catenin and allowing it to
translocate to the nucleus where it stimulates transcription of
neurogenesis-related genes. These effects of DISC1/Dixdc1
silencing can be rescued by expression of b-catenin or by inhibiting
GSK3b (Mao et al., 2009; Singh et al., 2010). Also, and of clinical
relevance, GSK3b is a well-established target for lithium chloride,
widely used in the management of bipolar disorder (Ross and
Margolis, 2009). GSK3b-speciﬁc inhibitors can also rescue hyper-
locomotion in open ﬁeld tests observed in mice expressing the
DISC1-L100P mutant or in which DISC1 has been silenced in the
hippocampus (Lipina et al., 2010a; Mao et al., 2009) as well as pre-
pulse and latent inhibition deﬁcits in the L100Pmouse (Lipina et al.,
2010a). Intriguingly, GSK3 activity is also regulated by the APP-
derived b-amyloid peptide (reviewed in Hernández et al., 2010).
Girdin (also known as KIAA1212, APE, GIV and HkRP1) is






















Fig. 1. 22 known DISC1-interacting proteins, the majority of which are found in or
around the centrosome. Proteins which are known to bind directly to each other are
linked by thick black lines, while proteins which are known to co-exist in the same
complex, but for which a direct-interaction has, to our knowledge, yet to be demon-
strated are linked by grey dashed lines. The circle linking dynein, dynactin, LIS1, NDE1
and NDEL1 signiﬁes that these ﬁve proteins complex with each other. Note that the
DISC1-CEP290, DISC1-AKAP450 and TNIK-AKAP450 interactions have only been shown
by yeast-2-hybrid screening and remain to be conﬁrmed, while Grb2 binds only to
a single isoform of PDE4D. Data on interactions with DISC1 and between DISC1-binding
partnerswere taken from the following papers: (Beard et al.,1999; Bradshawet al., 2008,
2009; Brandon et al., 2004; Burdick et al., 2008; Camargo et al., 2007; Chang et al., 2006;
Collins et al., 2008; Ewing et al., 2007; Faulkner et al., 2000; Feng et al., 2000; Guo et al.,
2006; Hattori et al., 2007; Hirohashi et al., 2006; Hutchins et al., 2010; Kim et al., 2004,
2008b; Kitagawa et al., 2000; McCahill et al., 2005; Millar et al., 2003, 2005; Miyoshi
et al., 2004; Morris et al., 2003; Murdoch et al., 2007; Niethammer et al., 2000; Ogawa
et al., 2005; Ozeki et al., 2003; Purohit et al., 1999; Sasaki et al., 2000; Sawamura et al.,
2008; Sayer et al., 2006; Shinoda et al., 2007; Singh et al., 2010; Smith et al., 2000;
Stehman et al., 2007; Sweeney et al., 2001; Tai et al., 2002; Takahashi et al., 2002; Taya
et al., 2007; Toyo-oka et al., 2005; Wang et al., 2010).
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Table 2
Studies which have found positive evidence of association between variants in genes encoding DISC1-interacting proteins and major mental illness. SNPs grouped together in
brackets indicate haplotypes. SNPs separated by a hyphen () indicate signiﬁcance when alleles are considered together, but not independently.
Gene Study Condition Sample SNP, haplotype or marker Notes
ATF4 Qu et al. (2008) Schizophrenia Han Chinese (rs17001266, rs4894) Males only










Nicodemus et al. (2010) Schizophrenia American rs10744743
rs3847960-rs203332
rs3847960-rs440299
CIT-DISC1 Nicodemus et al. (2010) Schizophrenia American rs10744743-rs1411771
CIT-NDEL1 Nicodemus et al. (2010) Schizophrenia American rs10744743-rs4791707
FEZ1 Rastogi et al. (2009) Schizophrenia Canadian (rs2845846, rs2849222)
NDE1 Hennah et al. (2007) Schizophrenia Finnish families (rs4781678, rs2242549,
rs881803, rs2075512)
Females only, conditioned
on DISC1 HEP3 haplotype
Burdick et al. (2008) Schizophrenia American Caucasian (rs8061376, rs4781679,
rs3784859, rs12934645)
Amongst DISC1 C704 carriers
NDEL1 Burdick et al. (2008) Schizophrenia American Caucasian (rs1391768, rs1391766,
rs931672, rs35261231)
Not amongst DISC1 C704 carriers
Tomppo et al. (2009a) Schizophrenia Finnish families rs17806986
(rs17806986, rs1391768,
rs1391766, rs3817003)
Nicodemus et al. (2010) Schizophrenia American rs4791707
PAFAH1B1 Rastogi et al. (2009) Schizophrenia Canadian families (rs8081803, rs12938775)
Nicodemus et al. (2010) Schizophrenia American rs12938775






Scottish (rs454755, rs3780103, rs6991775)
American trios D8S261






Moens et al. (2010) Schizophrenia Swedish rs13276297
European rs445422 Meta-analysis of populations
in Datta & Moens studies
rs208747
PCNT Anitha et al. (2009) Schizophrenia Japanese rs2249057
(rs9981892, rs2249057)
(rs9981892, rs2249057, rs2839222)
Numata et al. (2009b) Major depression Japanese rs3788265
rs2073376
PDE4B Pickard et al. (2007) Schizophrenia Scottish (rs2503166, rs583018, rs526772) Females only










Numata et al. (2008a) Schizophrenia Japanese rs2180335
rs910694
rs472952
Numata et al. (2009a) Major depressive
disorder
Japanese rs472952 Not replicated
in second sample
Rastogi et al. (2009) Schizophrenia Canadian (rs614350, rs2503174)
(rs12068439, rs12743648)
(rs2503174, rs1577844)




et al., 2009; Kim et al., 2009), over-expression of which leads to
adult-born neurons of the dentate gyrus displaying enhanced
dendritic growth, increased dendritic number and over-extended
migration into the outer granule cell layer andmolecular layer (Kim
et al., 2009), mirroring the effects of DISC1 depletion (Duan et al.,
2007). Incorrect neuronal localisation and impaired mossy ﬁbre
development are also seen in girdin knock-out mice (Enomoto et al.,
2009). These effects of girdin appear to bemediated via its ability to
bind to and increase the activity of the serine/threonine kinase Akt
(Anai et al., 2005). DISC1 depletion increases Akt activity
(Hashimoto et al., 2006) at least in part through binding to girdin
and preventing its Akt-stimulating activity (Kim et al., 2009). In
agreement with this, use of rapamycin to inhibit mTOR, which lies
downstream of Akt signalling, can rescue the neuronal abnormal-
ities caused by Girdin over-expression or DISC1 knock-down (Kim
et al., 2009). Akt is also a negative modulator of GSK3b, although
an inhibitor of GSK3b was not seen to rescue these girdin-related
developmental defects (Kim et al., 2009).
2.3. DISC1-binding partners at the post-synaptic density
In addition to modulating the proliferation, migration and
integration of neurons, it can also be postulated that proteins of the
DISC1 complex might impact upon major mental illness by
modulation of synaptic transmission. In support of this, DISC1 and
several of its binding partners, including citron, PDE4B, LIS1, NDE1
and NDEL1, have been found to localise to the post-synaptic density
(PSD, Bradshaw et al., 2008; Clapcote et al., 2007; Furuyashiki et al.,
1999; Kirkpatrick et al., 2006; Niethammer et al., 2000; Zhang et al.,
1999). To date however, relatively little is understood of the
synaptic functions of these proteins.
In contrast, more is known about the role of the PSD-localised
DISC1 interactor TNIK (Camargo et al., 2007), a kinase expressed in
the mouse hippocampus (Wang et al., 2010) whose activity is
involved in regulation of the cytoskeleton (Fu et al., 1999). DIS-
C1-binding inhibits the kinase activity of TNIK, leading to the
degradation of several key PSD proteins, including the important
structural protein PSD95, and modulating the surface expression of
glutamate receptor 1 (GluR1, Wang et al., 2010). More generally,
knock-down of DISC1 expression leads to an increase in the
formation of spines and GluR1-expessing synapses in mature rat
neurons, a process dependent on its interaction with kalirin-7
(Kal7, Hayashi-Takagi et al., 2010). Kal7-dependent regulation of
spine formation occurs through its activity as a GDP/GTP exchange
factor for Rac1 (Xie et al., 2007), and DISC1 appears to inhibit its
activity by binding to Kal7 and PSD95 (Hayashi-Takagi et al., 2010).
Activation of NMDA receptors causes dissociation of DISC1, Kal7
and PSD95, making Kal7 available to modulate Rac1 and thus spine
structure (Hayashi-Takagi et al., 2010). Thus DISC1 appears to
modulate the formation of PSD complexes and dendritic spines
through regulation of TNIK, Kal7 and Rac1.
Other DISC1 interactors of potential importance at the synapse
include APP (Young-Pearce et al., 2010), given its involvement in
spine formation (Lee et al., 2009) and enhancement of NMDA
receptor activity (Hoe et al., 2009). Another DISC1 interactor,
Activating Transcription Factor 4 (ATF4 or CREB2, Millar et al., 2003;
Morris et al., 2003; Sawamura et al., 2008) is known to bind to
GABAB receptors in the synapse (Nehring et al., 2000; Vernon et al.,
2001; White et al., 2000), and its transport from the synapse to the
nucleus, where it acts as a transcriptional repressor, is implicated in
long-term depression and memory (Lai et al., 2008).
3. Roles of DISC1-interacting proteins in signalling
Another important theme in DISC1 biology is its role in a wide
variety of signalling pathways, including the GSK3b and Akt path-
ways discussed above in Section 2.2. A third such pathway involves
signalling by the ubiquitous secondary messenger molecule cAMP.
The phosphodiesterase 4 family of enzymes degrade cAMP
(reviewed in Houslay and Adams, 2003) and isoforms from all four
PDE4 subtypes (PDE4A-D) have been demonstrated to interact with
DISC1 (Millar et al., 2005; Murdoch et al., 2007). DISC1 binds PDE4
in a low-activity conformation (Millar et al., 2005; Murdoch et al.,
2007) and PDE4 activity is diminished in mice with a mutation,
Q31L, in a PDE4-binding site on DISC1 (Clapcote et al., 2007).
Downstream effects of DISC1ePDE4 interaction remain to be
determined, but are likely to include regulation of the activity of
cAMP-dependent Protein Kinase A (PKA), substrates of which
include the DISC1-interactors NDE1 (Bradshaw et al., 2008) and
ATF4 (Elefteriou et al., 2005). In support of this, over-expression of
DISC1 exaggerates the repression of CRE-dependent gene tran-
scription caused by ATF4 in response to PKA (Karpinski et al., 1992;
Sawamura et al., 2008). PDE4 is the known target for rolipram and
other small molecules which have anti-depressant and anti-
psychotic activity in rodent models (Kanes et al., 2007; Maxwell
et al., 2004; O’Donnell and Zhang, 2004).
Another family of proteins heavily implicated in major mental
illness are the neuregulins and the ErbB family of receptors for
which cleaved NRG domains act as ligands (reviewed in Schmitt
et al., 2008). Intriguingly, NRG1 and NRG2 signalling is seen to
increase the expression of a speciﬁc DISC1 isoform in a process
dependant on the activity of BACE to cleave neuregulins, forming
extracellular peptide ligands (Seshadri et al., 2010). This pathway
appears to be mediated by PI3 K/Akt signalling and is transcription-
dependent (Seshadri et al., 2010). Downstream effects of NRG1
signalling include inducing the expression and activity of ATF4
(Talukder et al., 2000). Expression of DISC1 also appears to be
upregulated following signalling by the neuropeptide PACAP, which
additionally stimulates interaction of DISC1 with DBZ (Hattori et al.,
Table 2 (continued )
Gene Study Condition Sample SNP, haplotype or marker Notes
PDE4D Tomppo et al. (2009a) Schizophrenia Finnish families rs1120303
(rs13190249, rs1120303, rs921942,
rs10805515, rs10514862)
TNIK Potkin et al. (2009) Schizophrenia associated
with a quantitative trait
American rs2088885
rs7627954
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2007). DISC1 is also implicated in dopamine signalling, which is
altered in several DISC1 mouse models (Ayhan et al., 2010; Lipina
et al., 2010b; Niwa et al., 2010). Silencing of DISC1 in rat striatal
neurons leads to loss of dopamine receptor-expressing cilia (Marley
and von Zastrow, 2010).
In summary, it is increasingly apparent that DISC1 is not simply
a scaffold for the formation of protein complexes, but more an
active hub for regulating divergent signalling pathways, including
PDE4/cAMP, Akt/mTOR and GSK3b/b-catenin that are each well
known to impact upon neurodevelopmental and/or psychiatric
illness. An interesting side point is the apparent convergence of the
DISC1 pathway with proteins involved in Alzheimer’s disease.
DISC1 is now known to interact with APP (Young-Pearse et al.,
2010), from which the b-amyloid peptide is derived, along with
the related APLP1 protein (Millar et al., 2003). DISC1 also inhibits
the activity of GSK3b (Mao et al., 2009), which is modulated by and
may also modulate b-amyloid peptides (Hernández et al., 2010),
and DISC1 levels are indirectly regulated by BACE (Seshadri et al.,
2010), the APP-cleaving enzyme. By implication, DISC1 plays
a critical role in integrating these otherwise independent pathways,
elaborating the details of which represents a key future challenge.
4. Genetic evidence implicating DISC1 interactors in
schizophrenia and related disorders
Several positive genetic association studies have been reported
for genes encoding DISC1 interactors (summarised in Table 2),
implying that multiple DISC1-related pathways need to be
considered as relevant to risk of psychopathology. ATF4, CIT
(encoding citron), FEZ1, NDE1, PAFAH1B1 (encoding LIS1), PCNT
(encoding pericentrin), PDE4D, TNIK and YWHAE (encoding 14-3-
33) are thus all implicated in schizophrenia, although some of these
are single studies or report modest associations that await ﬁrm
replication, with some studies failing to replicate (Table 3 and
references therein). Replication of genetic association between one
or more SNPs and major mental illness supports PDE4B, NDEL1 and
PCM1 in their own right (Table 2 and references therein).
It is important here also to distinguish between the strict
statistical tests for signiﬁcance that must be applied to gene-wide
or genome-wide test of association and the insight which can be
gained from speciﬁc mutations in individual cases and families
(Mitchell and Porteous, 2009; Porteous, 2008). Thus, in much the
same way as DISC1 was discovered at a translocation breakpoint
(Blackwood et al., 2001; Millar et al., 2000; St Clair et al., 1990),
PDE4Bwas found to be directly disrupted by a t(1:16) translocation
in a proband with schizophrenia, who also had an affected cousin
(Millar et al., 2005). Similarly, both deletions and duplications at
chromosomal locus 16p13.1, containing the NDE1 gene, are signif-
icantly over-represented in schizophrenia patients in Scottish and
other European populations, with a similar deletion also seen in an
AfricaneAmerican individual with the condition (Ingason et al.,
2011; Need et al., 2009). Ultra-rare missense mutations in
patients with schizophrenia have been reported for APP (Jones
et al., 1992) PCM1 (Kamiya et al., 2008), and indeed DISC1 (Song
et al., 2008). These rare mutations point the ﬁnger directly at
these genes and associated pathways, and further demonstrate
their biological relevance.
Evidence has also been reported of transcripts encoding several
of these proteins being either up- or down-regulated in brain tissue
of individuals with psychiatric illness, compared to that from
healthy controls (Table 4 and references therein). Such differences
in mRNA expression could be the result of direct mutation in those
genes, or indirectly, due to dysregulation of transcription factors or
other modulatory proteins. Additionally, certain DISC1 SNPs are
Table 3
Studies which failed to ﬁnd evidence of association of mental illness with any SNP
examined of a gene encoding a DISC1-interacting protein.
Gene Study Condition Population
ATF4 Kakiuchi et al. (2007) Bipolar disordera Japanese
DBZ Anitha et al. (2009) Schizophrenia Japanese
Bipolar disorder Japanese
FEZ1 Yamada et al. (2004) Bipolar disorder Japanese
Schizophreniaa Japanese
Hodgkinson et al. (2007) Schizophrenia American Caucasian
African American
Koga et al. (2007) Schizophrenia Japanese
Nicodemus et al. (2010) Schizophreniab American
GRB2 Ikeda et al. (2008) Schizophrenia Japanese
KIF5A Ikeda et al. (2008) Schizophrenia Japanese
NDE1 Numata et al. (2008b) Schizophrenia Japanese
Nicodemus et al. (2010) Schizophreniab American
NDEL1 Kähler et al. (2008) Schizophrenia Scandanavian
Ikeda et al. (2008) Schizophrenia Japanese
Rastogi et al. (2009) Schizophrenia Canadian
PAFAH1B1 Ikeda et al. (2008) Schizophrenia Japanese
Kähler et al. (2008) Schizophrenia Scandanavian
PCNT Numata et al. (2010) Schizophreniaa Japanese
Anitha et al. (2008) Bipolar disorder Japanese
PDE4B Holliday et al. (2009) Schizophreniac Tamil Nadu, India
Rastogi et al. (2009) Schizophreniaa Canadian
Kähler et al. (2009) Schizophreniaa Scandinavian
Bipolar disorder Scandinavian
YWHAE Kähler et al. (2008) Schizophrenia Scandanavian
a These studies found nominal association with one or more SNPs, but these did
not survive correction for multiple testing.
b Nicodemus et al. were principally looking for evidence of genetic epistasis
between genes rather than evidence that individual SNPs were associated with
schizophrenia.
c Holliday et al. found a risk locus proximal to PDE4B in a ethnically homogenous
sample, but found no evidence of association to PDE4B itself.
Table 4
Studies which have found levels of transcripts encoding DISC1-interacting proteins to be signiﬁcantly altered in RNA from individuals with major mental illness compared to
healthy controls.
Gene Study Condition Associated expression proﬁle
FEZ1 Lipska et al. (2006) Schizophrenia Reduced in the hippocampus and
dorsolateral prefrontal cortex
NDE1 Fatemi et al. (2010) Schizophrenia Increased in cerebellum
Bipolar disorder Increased in cerebellum
Major depression Increased in cerebellum
NDEL1 Lipska et al. (2006) Schizophrenia Reduced in the hippocampus
PAFAH1B1 Lipska et al. (2006) Schizophrenia Reduced in the hippocampus and
dorsolateral prefrontal cortex
PDE4B Numata et al. (2009a) Major depression Increased in peripheral leukocytes
TNIK Glatt et al. (2005) Schizophrenia Increased in dorsolateral prefrontal cortex
Matigian et al. (2007) Bipolar disorder Increased in lymphoblastoids
(relative to healthy monozygotic twin)
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associated with reduced levels of FEZ1, LIS1 and NDEL1 transcripts
in the hippocampus (Lipska et al., 2006).
Additionally, as one would predict biologically, evidence for
epistatic interaction is emerging: three-way interaction between
speciﬁc SNPs in CIT, DISC1 and NDEL1 has been reported for
schizophrenia (Nicodemus et al., 2010); there is strong statistical
interplay between the HEP3 haplotype and NDE1 in the Finnish
population (Hennah et al., 2007) and haplotypes of NDE1 and
NDEL1 show association that is dependent on the Ser or Cys variant
at position 704 in DISC1 (Burdick et al., 2008).
Although the emphasis of genetic studies to date has been on
their potential pathological impact, it is emerging that common
variants of DISC1 and its interactors impact on normal variation and
intermediate phenotypes, for example memory tasks (Burdick
et al., 2005; Cannon et al., 2005; Hennah et al., 2005) and in
quantitative measures of personality and mood (Harris et al., 2010).
We have recently reported (Hennah and Porteous, 2009) that
common cis-acting variants of DISC1 modulate expression within
normal subjects by up to 20%. Moreover, variants in DISC1, PDE4 and
NDE1 impact on the expression of genes involved in the cytoskel-
eton, neurosignalling and sensory perception, and are signiﬁcantly
enriched for current drug development targets in psychiatry.
In a similar vein, the recent demonstration of at least ﬁfty
different DISC1 transcripts including an abundance that are speciﬁc
to foetal development and some for which expression is altered in
the hippocampus of those suffering from schizophrenia or carrying
DISC1 schizophrenia-risk alleles (Nakata et al., 2009), raised
a whole new series of questions about how DISC1 expression is
regulated, and with what effect on neurodevelopment and
signalling.
5. Caveats and limitations
Whereas the growing literature on DISC1 and the DISC1
pathway, as summarised here, provides multiple avenues of
promising research to pursue that is relevant to neurodevelopment,
signalling and psychopathology, there are gaps and limitations. For
example, with respect to the DISC1 interactome derived fromyeast-
two-hybrid analysis, only a minority of putative DISC1 interactors
have been formally tested and conﬁrmed by co-immunoprecipita-
tion or co-localisation in native tissue. Although multiple tran-
scripts and protein isoforms of DISC1 have been described, the
functional role of the former and the amino-acid sequence of the
later remain to be determined. Evidence from the original family
from which DISC1 was identiﬁed is consistent with a simple hap-
loinsufﬁciency model, but in the absence of patient tissue other
than lymphoblastoid cell lines, it is not possible to rule out
a dominant negative effect of hypothetical truncated or fusion
DISC1 protein expression during development or in the adult brain.
This family is an example of an ultra rare, in this case unique,
genetic event revealing a more general genetic contribution though
other genetic variants at the locus. A number of amino-acid
substitutions in DISC1 been described and regulatory mutations
hypothecated from association evidence, but a comprehensive
analysis of all possible mutations awaits the results of large scale
resequencing studies. Our understanding of the biological conse-
quences of S704C and L607F, the best studied to date, remain
partial. Regarding the cell and animal models used to test for bio-
logical effects, these do not as yet model known clinical variants,
nor, for obvious reasons, do the models allow testing of psychiatric
phenotypes, only at best surrogates and proxies. That said, a still
modest, but growing body of evidence is making links between
mouse models and human studies through comparative brain
histology and imaging (reviewed in Johnstone et al., 2010). Thus,
despite the remarkable progress, much remains to be done not just
in vitro or in model systems, but in clinical studies too.
6. Summary and conclusions
The complexities of schizophrenia and related psychiatric illness
were never likely to yield to single methodologies or models, but
a combined genetic and biological approach offers promise. From
what might have been viewed as an unlikely start point, the
molecular genetic characterisation of a single family with a high
loading for psychiatric illness, the insights from the discovery of
DISC1 have been manifold and far-reaching, a paradigm for future
work. It is now not so much a question of the role of DISC1 per se,
but much more about the DISC1 pathway in neurodevelopment
and signalling, brought to light through the multiplicity of DISC1-
interacting proteins. Mechanistic details remain to be ﬁlled in and
potential therapeutic targets evaluated. But in the decade since
DISC1 was cloned, much progress towards these goals has been
made by a combination of genetics, biochemistry, neurobiology and
animal models. The next decade promises further exciting pros-
pects to enhance our understanding of the DISC1 pathway to the
beneﬁt of patients.
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